Kristin Yarema insider trades

Open-market stock purchases and sales by Kristin Yarema, Chief Executive Officer at ImageneBio, Inc, from SEC Form 4 filings since Feb 18, 2020.

Track record: 0% of 3 scored buys are up 5% or more since purchase, averaging -35%.

Recent trades

DateStockTradeValue
Aug 14, 2026IMA ImageneBio, IncBought (not open market)—
Aug 14, 2026IMA ImageneBio, IncBought (not open market)—
Aug 14, 2026IMA ImageneBio, IncBought (not open market)—
Jul 25, 2026IMA ImageneBio, IncBought (not open market)—
Jul 25, 2026IMA ImageneBio, IncSold (not open market)—
Mar 16, 2026IMA ImageneBio, IncBought (not open market)—
Mar 16, 2026IMA ImageneBio, IncBought (not open market)—

Companies traded

  • IMA ImageneBio, Inc: other filings, last Aug 14, 2026
  • PSTX Poseida Therapeutics, Inc: other filings, last Jan 8, 2025
  • ATRA Atara Biotherapeutics, Inc: 3 buys, 1 sale, last Mar 1, 2022

Get free alerts when Kristin Yarema files a new trade →